Write For Us

Martin Shkreli’s former firm to pay $40m in price-gouging settlement

Sponsored Post Vitamin D2 Canada Persia
65 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
A US medical company once owned by Martin Shkreli has agreed to pay $40m to settle allegations of price gouging.
But Shkreli is standing trial in New York on related charges.
The former hedge fund manager gained notoriety in 2015 after he hiked the price of a lifesaving drug from $17 a tablet to a whopping $750.

Al Jazeera’s Rosiland Jordan reports from Washington, DC.

- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/

#MartinShkreli #PharmaBro #Vyera
Category
World
Tags
2015 US drug-pricing scandal, Al Jazeera, Daraprim
Sign in or sign up to post comments.
Be the first to comment